Advanced in Spontaneous Coronary Artery Dissection (SCAD)

Paul J. Vermeersch

AZ Sint Jan Brugge AV
Brugge, VLG, BE 
Advanced in Spontaneous Coronary Artery Dissection (SCAD)
AZ Sint Jan Brugge AV
Brugge, VLG, BE 
OverviewLocationsClinical Research

Overview

Paul Vermeersch practices in Brugge, Belgium. Mr. Vermeersch is rated as an Advanced expert by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). His top areas of expertise are Coronary Heart Disease, Spontaneous Coronary Artery Dissection (SCAD), Congenital Coronary Artery Malformation, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Spontaneous Coronary Artery Dissection (SCAD).

Gender
Male

Locations

AZ Sint Jan Brugge AV
Brugge, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Preprocedural Assessment of Anatomy and Device Sizing With CT and 3D Simulation in Left Atrial Appendage Occlusion: the PRECISE LAAO Registry
Preprocedural Assessment of Anatomy and Device Sizing With CT and 3D Simulation in Left Atrial Appendage Occlusion: the PRECISE LAAO Registry
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Procedure
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

89 Total Publications

Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study.
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: May 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vermeersch's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile